VIPoma surgery: Difference between revisions
Jump to navigation
Jump to search
Madhu Sigdel (talk | contribs) No edit summary |
Madhu Sigdel (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Surgery is the mainstay of treatment for VIPoma.<ref name=surgery>Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref> | Surgery is the mainstay of treatment for VIPoma.<ref name="surgery">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref> | ||
==Surgery== | ==Surgery== | ||
*Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.<ref name=surgery>Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref> | *Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.<ref name="surgery">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref> | ||
*If the tumor cannot be removed completely, surgical debulking may have palliative | *If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.<ref name="sp">Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref> | ||
*In nonresectable liver metastases, Hepatic TACE (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.<ref name="pmid4981295">{{cite journal| author=Blaise A, Girardet JL| title=[Study of the magnetic properties of siderophilin]. | journal=C R Acad Sci Hebd Seances Acad Sci D | year= 1969 | volume= 269 | issue= 10 | pages= 966-8 | pmid=4981295 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4981295 }}</ref> | |||
<gallery>Image:Intra_operative.jpg| Intraoperative aspect of liver lesions (arrows).<ref name="APODACA-TORREZTRIVIÑO2014">{{cite journal|last1=APODACA-TORREZ|first1=Franz R.|last2=TRIVIÑO|first2=Marcello|last3=LOBO|first3=Edson José|last4=GOLDENBERG|first4=Alberto|last5=TRIVIÑO|first5=Tarcísio|title=Extra-pancreatic vipoma|journal=ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)|volume=27|issue=3|year=2014|pages=222–223|issn=0102-6720|doi=10.1590/S0102-67202014000300015}}</ref> | <gallery>Image:Intra_operative.jpg| Intraoperative aspect of liver lesions (arrows).<ref name="APODACA-TORREZTRIVIÑO2014">{{cite journal|last1=APODACA-TORREZ|first1=Franz R.|last2=TRIVIÑO|first2=Marcello|last3=LOBO|first3=Edson José|last4=GOLDENBERG|first4=Alberto|last5=TRIVIÑO|first5=Tarcísio|title=Extra-pancreatic vipoma|journal=ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)|volume=27|issue=3|year=2014|pages=222–223|issn=0102-6720|doi=10.1590/S0102-67202014000300015}}</ref> | ||
Revision as of 16:41, 9 January 2018
VIPoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
VIPoma surgery On the Web |
American Roentgen Ray Society Images of VIPoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
Surgery is the mainstay of treatment for VIPoma.[1]
Surgery
- Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.[1]
- If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.[2]
- In nonresectable liver metastases, Hepatic TACE (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.[3]
-
Intraoperative aspect of liver lesions (arrows).[4]
References
- ↑ 1.0 1.1 Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.
- ↑ Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/
- ↑ Blaise A, Girardet JL (1969). "[Study of the magnetic properties of siderophilin]". C R Acad Sci Hebd Seances Acad Sci D. 269 (10): 966–8. PMID 4981295.
- ↑ APODACA-TORREZ, Franz R.; TRIVIÑO, Marcello; LOBO, Edson José; GOLDENBERG, Alberto; TRIVIÑO, Tarcísio (2014). "Extra-pancreatic vipoma". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 27 (3): 222–223. doi:10.1590/S0102-67202014000300015. ISSN 0102-6720.